AstraZeneca PLC (AZN)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4,893	5,711	5,488	5,840	6,166	6,329
Short-Term Investments	75	30	166	122	239	69
Cash & Short-Term Investments	4,968	5,741	5,654	5,962	6,405	6,398
Cash Growth	-30.11%	1.54%	-5.17%	-6.92%	0.11%	-19.95%
Accounts Receivable	14,330	15,177	12,972	12,126	10,521	9,644
Inventory	6,932	6,557	5,288	5,424	4,699	8,983
Other Current Assets	1,735	1,248	1,913	1,542	968	1,219
Total Current Assets	27,965	28,723	25,827	25,054	22,593	26,244
Net Property, Plant & Equipment	16,300	14,703	11,647	10,502	9,449	10,171
Other Intangible Assets	37,723	37,846	37,177	38,089	39,307	42,387
Goodwill	21,181	21,242	21,025	20,048	19,820	19,997
Long-Term Investments	2,916	2,525	1,900	1,677	1,142	1,237
Other Long-Term Assets	9,748	9,035	6,459	5,749	4,172	5,327
Total Assets	115,833	114,074	104,035	101,119	96,483	105,363

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	22,893	25,280	22,465	22,374	19,040	18,938
Current Portion of Long-Term Debt	5,808	3,104	2,337	5,129	5,314	1,660
Current Portion of Leases	426	382	339	271	228	233
Other Current Liabilities	2,426	1,851	2,725	2,768	1,711	1,763
Total Current Liabilities	31,553	30,617	27,866	30,542	26,293	22,594
Long-Term Debt	23,683	24,715	26,506	22,365	22,965	28,134
Long-Term Leases	2,322	1,421	1,113	857	725	754
Other Long-Term Liabilities	7,905	8,602	7,679	8,189	9,442	14,594
Total Long-Term Liabilities	33,910	34,738	35,298	31,411	33,132	43,482
Total Liabilities	65,463	65,355	63,164	61,953	59,425	66,076

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	388	388	388	388	387	387
Additional Paid-in Capital	37,315	35,867	35,827	35,789	35,756	35,727
Accumulated Other Comprehensive Income	-	1,440	1,411	1,464	1,468	1,444
Retained Earnings	12,592	10,972	3,160	1,502	-574	1,710
Total Common Shareholders' Equity	50,295	48,667	40,786	39,143	37,037	39,268
Minority Interest	75	52	85	23	21	19
Shareholders' Equity	50,370	48,719	40,871	39,166	37,058	39,287
Total Liabilities & Equity	115,833	114,074	104,035	101,119	96,483	105,363

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	32,239	29,622	30,295	28,622	29,232	30,781
Net Cash (Debt)	-27,271	-23,881	-24,641	-22,660	-22,827	-24,383
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-17.47	-15.29	-15.77	-14.51	-14.63	-17.09
Book Value	50,295	48,667	40,786	39,143	37,037	39,268
Book Value Per Share	32.21	31.16	26.09	25.06	23.74	27.52
Tangible Book Value	-8,609	-10,421	-17,416	-18,994	-22,090	-23,116
Tangible Book Value Per Share	-5.51	-6.67	-11.14	-12.16	-14.16	-16.20

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jul 27, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error